[89]Zr-Df-IAb2M

· ImaginAb, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [89]Zr-Df-IAb2M, covering 2015-06-02 to 2015-06-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer [Phase 2]

See pricing